Clinical Role of Vascular Endothelial Growth Factor (VEGF) and Hepatocyte Growth Factor (HGF) in Type-2 Diabetic Patients

Michiyo Takayama, Ken Shinmura, Hiroshi Hasegawa, Masato Tani, Toshiko Wakabayashi, Kei Shinoda, Susumu Ishida, Masakazu Yamada

Research output: Contribution to journalArticle

Abstract

We performed two studies to investigate the clinical roles of VEGF and HGF in diabetes mellitus. (1) Serum concentrations of VEGF and HGF were measured in type-2 diabetic patients (DM, n = 74) and control subjects (C, n = 44) by enzyme-linked immunosorbent assay, and their relationship to fasting plasma glucose (FPG), hemoglobin Aic, total cholesterol, high-density lipoprotein cholesterol (HDL-C), liver function, systolic blood pressure, smoking, and diabetic angiopathy were analyzed. (2) VEGF and HGF concentrations were measured in both the serum and anterior aqueous humor of type-2 diabetic patients (n = 33) and non-diabetic patients (n = 12) who underwent eye surgery, and their correlations with diabetic retinopathy were determined. (1) There were no differences in serum VEGF between C and DM, but, serum VEGF was significantly higher in DM with diabetic angiopathy. Serum HGF was higher in DM and smokers, and inversely correlated with HDL-C and FPG. (2) Neither serum VEGF nor HGF were associated with retinopathy, but anterior aqueous humor VEGF was extremely higher and HGF tended to be higher in DM with preproliferative diabetic retinopathy. VEGF and HGF were not correlated in serum, but a positive correlation was observed in anterior aqueous humor. These results suggest that VEGF and HGF affect diabetic retinopathy, however, no relationship to diabetic macroangiopathy could be detected.

Original languageEnglish
Pages (from-to)347-354
Number of pages8
JournalJournal of the Japan Diabetes Society
Volume43
Issue number5
DOIs
Publication statusPublished - 2000

Fingerprint

Hepatocyte Growth Factor
Vascular Endothelial Growth Factor A
Serum
Aqueous Humor
Diabetic Retinopathy
Diabetic Angiopathies
HDL Cholesterol
Fasting
Vascular Endothelial Growth Factor C
Blood Pressure
Glucose
Diabetes Mellitus
Hemoglobins
Smoking
Enzyme-Linked Immunosorbent Assay
Cholesterol
Liver

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Clinical Role of Vascular Endothelial Growth Factor (VEGF) and Hepatocyte Growth Factor (HGF) in Type-2 Diabetic Patients. / Takayama, Michiyo; Shinmura, Ken; Hasegawa, Hiroshi; Tani, Masato; Wakabayashi, Toshiko; Shinoda, Kei; Ishida, Susumu; Yamada, Masakazu.

In: Journal of the Japan Diabetes Society, Vol. 43, No. 5, 2000, p. 347-354.

Research output: Contribution to journalArticle

Takayama, Michiyo ; Shinmura, Ken ; Hasegawa, Hiroshi ; Tani, Masato ; Wakabayashi, Toshiko ; Shinoda, Kei ; Ishida, Susumu ; Yamada, Masakazu. / Clinical Role of Vascular Endothelial Growth Factor (VEGF) and Hepatocyte Growth Factor (HGF) in Type-2 Diabetic Patients. In: Journal of the Japan Diabetes Society. 2000 ; Vol. 43, No. 5. pp. 347-354.
@article{b278e03ab21c4399b80ba6cec52cbd17,
title = "Clinical Role of Vascular Endothelial Growth Factor (VEGF) and Hepatocyte Growth Factor (HGF) in Type-2 Diabetic Patients",
abstract = "We performed two studies to investigate the clinical roles of VEGF and HGF in diabetes mellitus. (1) Serum concentrations of VEGF and HGF were measured in type-2 diabetic patients (DM, n = 74) and control subjects (C, n = 44) by enzyme-linked immunosorbent assay, and their relationship to fasting plasma glucose (FPG), hemoglobin Aic, total cholesterol, high-density lipoprotein cholesterol (HDL-C), liver function, systolic blood pressure, smoking, and diabetic angiopathy were analyzed. (2) VEGF and HGF concentrations were measured in both the serum and anterior aqueous humor of type-2 diabetic patients (n = 33) and non-diabetic patients (n = 12) who underwent eye surgery, and their correlations with diabetic retinopathy were determined. (1) There were no differences in serum VEGF between C and DM, but, serum VEGF was significantly higher in DM with diabetic angiopathy. Serum HGF was higher in DM and smokers, and inversely correlated with HDL-C and FPG. (2) Neither serum VEGF nor HGF were associated with retinopathy, but anterior aqueous humor VEGF was extremely higher and HGF tended to be higher in DM with preproliferative diabetic retinopathy. VEGF and HGF were not correlated in serum, but a positive correlation was observed in anterior aqueous humor. These results suggest that VEGF and HGF affect diabetic retinopathy, however, no relationship to diabetic macroangiopathy could be detected.",
author = "Michiyo Takayama and Ken Shinmura and Hiroshi Hasegawa and Masato Tani and Toshiko Wakabayashi and Kei Shinoda and Susumu Ishida and Masakazu Yamada",
year = "2000",
doi = "10.11213/tonyobyo1958.43.347",
language = "English",
volume = "43",
pages = "347--354",
journal = "Journal of the Japan Diabetes Society",
issn = "0021-437X",
publisher = "Japan Diabetes Society",
number = "5",

}

TY - JOUR

T1 - Clinical Role of Vascular Endothelial Growth Factor (VEGF) and Hepatocyte Growth Factor (HGF) in Type-2 Diabetic Patients

AU - Takayama, Michiyo

AU - Shinmura, Ken

AU - Hasegawa, Hiroshi

AU - Tani, Masato

AU - Wakabayashi, Toshiko

AU - Shinoda, Kei

AU - Ishida, Susumu

AU - Yamada, Masakazu

PY - 2000

Y1 - 2000

N2 - We performed two studies to investigate the clinical roles of VEGF and HGF in diabetes mellitus. (1) Serum concentrations of VEGF and HGF were measured in type-2 diabetic patients (DM, n = 74) and control subjects (C, n = 44) by enzyme-linked immunosorbent assay, and their relationship to fasting plasma glucose (FPG), hemoglobin Aic, total cholesterol, high-density lipoprotein cholesterol (HDL-C), liver function, systolic blood pressure, smoking, and diabetic angiopathy were analyzed. (2) VEGF and HGF concentrations were measured in both the serum and anterior aqueous humor of type-2 diabetic patients (n = 33) and non-diabetic patients (n = 12) who underwent eye surgery, and their correlations with diabetic retinopathy were determined. (1) There were no differences in serum VEGF between C and DM, but, serum VEGF was significantly higher in DM with diabetic angiopathy. Serum HGF was higher in DM and smokers, and inversely correlated with HDL-C and FPG. (2) Neither serum VEGF nor HGF were associated with retinopathy, but anterior aqueous humor VEGF was extremely higher and HGF tended to be higher in DM with preproliferative diabetic retinopathy. VEGF and HGF were not correlated in serum, but a positive correlation was observed in anterior aqueous humor. These results suggest that VEGF and HGF affect diabetic retinopathy, however, no relationship to diabetic macroangiopathy could be detected.

AB - We performed two studies to investigate the clinical roles of VEGF and HGF in diabetes mellitus. (1) Serum concentrations of VEGF and HGF were measured in type-2 diabetic patients (DM, n = 74) and control subjects (C, n = 44) by enzyme-linked immunosorbent assay, and their relationship to fasting plasma glucose (FPG), hemoglobin Aic, total cholesterol, high-density lipoprotein cholesterol (HDL-C), liver function, systolic blood pressure, smoking, and diabetic angiopathy were analyzed. (2) VEGF and HGF concentrations were measured in both the serum and anterior aqueous humor of type-2 diabetic patients (n = 33) and non-diabetic patients (n = 12) who underwent eye surgery, and their correlations with diabetic retinopathy were determined. (1) There were no differences in serum VEGF between C and DM, but, serum VEGF was significantly higher in DM with diabetic angiopathy. Serum HGF was higher in DM and smokers, and inversely correlated with HDL-C and FPG. (2) Neither serum VEGF nor HGF were associated with retinopathy, but anterior aqueous humor VEGF was extremely higher and HGF tended to be higher in DM with preproliferative diabetic retinopathy. VEGF and HGF were not correlated in serum, but a positive correlation was observed in anterior aqueous humor. These results suggest that VEGF and HGF affect diabetic retinopathy, however, no relationship to diabetic macroangiopathy could be detected.

UR - http://www.scopus.com/inward/record.url?scp=85024740747&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85024740747&partnerID=8YFLogxK

U2 - 10.11213/tonyobyo1958.43.347

DO - 10.11213/tonyobyo1958.43.347

M3 - Article

AN - SCOPUS:85024740747

VL - 43

SP - 347

EP - 354

JO - Journal of the Japan Diabetes Society

JF - Journal of the Japan Diabetes Society

SN - 0021-437X

IS - 5

ER -